carina

Collaboration with Davide Seruggia In biomedicine, collaboration is more than a buzzword—it’s an essential component of advancing our understanding of complex diseases. As technology and scientific knowledge evolve, the scope of research has expanded to include numerous specialized fields, each bringing unique insights and tools. Consequently, biomedicine relies increasingly on interdisciplinary research groups, where scientists […]

How to Combat Fungal Infections in Immunocompromised Patients? (Vienna, 17. 10. 2024) A new study from the St. Anna Children’s Cancer Research Institute (St. Anna CCRI) warns of the hidden dangers of invasive fungal infections in immunocompromised patients. The international research team, led by scientists Chantal Lucini, Klára Obrová, and Thomas Lion, has found that

ESCCA Conference 2024: Advancements in Clinical Cell Analysis Margarita Maurer-Granofszky, researcher of the Dworzak group, was invited to present her research at the ESCCA Conference 2024. In her presentations, she highlighted the importance of detecting minimal/measurable residual disease (MRD) in children with acute myeloid leukemia (AML) and how new technologies like artificial intelligence (AI) can

New Insights into Risk Factors for a Subtype of Acute Lymphoblastic Leukemia A team around Sabine Strehl and Dagmar Schinnerl has made significant progress in studying a subtype of B-cell acute lymphoblastic leukemia. The research findings, recently published in the Blood Cancer Journal, shed new light on the specific characteristics and risk factors of this

Resistance is Futile: DOC Fellowship for Cancer Resistance Research Leonie Lehmayer, a dedicated early-career researcher at St. Anna Children’s Cancer Research Institute, has recently been awarded a prestigious DOC Fellowship from the Austrian Academy of Sciences. Her PhD project focuses on studying enhancers and their role in drug resistance and relapse in cancer patients. Many

Replacing animal testing for Langerhans cell histiocytosis Caroline Hutter’s group at St. Anna CCRI recently received a major grant from the FWF to develop advanced, animal-free therapeutic approaches for the treatment of Langerhans cell histiocytosis (LCH). This rare disease, caused by an excessive accumulation of langerin expressing cells, poses a major challenge, especially for young

When Acute Lymphoblastic Leukemia (ALL) Transforms (Vienna, 05.04.2024) Acute lymphoblastic leukemia (ALL) is highly treatable. However, for new treatment methods in personalized medicine, subtypes of this leukemia must be studied more thoroughly. A team of researchers from St. Anna Children’s Cancer Research Institute and the University of Padua has now made another step forward in

The two faces of neutrophils in tumor biology (Vienna, 26.03.2024) Neutrophils are the most common white blood cells and an important component of the immune system. They help in the defense against pathogens and in the healing of injuries. They are also suspected to play a role in tumor development. A team from St. Anna

Exploring Horizons: SIOPEN Translational Research Meeting in Vienna (Vienna, 31.1.2024) Over the past three days, scientists from leading institutes such as St. Anna CCRI, Charite, Curie, Prinses Maxima Center, University of Leeds and the Vall d’Hebron University Hospital engaged in dynamic discussions on pivotal topics, spanning the realms of Liquid Biopsies, Tumor Biology, and New

Inaugural International Workshop on Innovative Models for Neuroblastoma Research (Vienna, 15.12.2023) On December 14th and 15th, the St. Anna Children’s Cancer Research Institute proudly hosted the inaugural International Workshop on Innovative Models for Neuroblastoma Research. This groundbreaking event gathered experts from Austria, the UK, the USA, Belgium, and Sweden, all converging at St. Anna CCRI

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future (Vienna, 05.12.2023) The St. Anna Children’s Cancer Research Institute celebrates 35 years at the forefront of scientific efforts against pediatric cancer. On this anniversary, the institute granted rare insights into its laboratories, showcasing the cutting-edge research that is conducted. Afterwards, the management presented

Joint Effort to Fast-Track Diagnoses (Vienna, 21.11.2023) Partners from two EU-funded initiatives, the European Joint Program for Rare Diseases (EJPRD) and The European Rare Diseases Research Coordination and Support Action (ERICA), converged at a joint conference in Amsterdam. The joint conference of EJPRD and ERICA served as a critical platform for participants to explore and

CLOSER Leukemia General Assembly: Sabine Strehl presents joint work package (Vienna, 20.11.2023) Sabine Strehl from St. Anna Childrens Cancer Research Institute, recently participated in the CLOSER Leukemia General Assembly in Santiago de Chile, presenting alongside her colleagues Patricia Rubio and Maria Sara Felice from Garrahan Hospital, Buenos Aires. They shared the latest outcomes from their

3rd School of Malignant Lymphomas in Ljubljana (Vienna, 19.10.2023) The 3rd School of Malignant Lymphomas in Ljubljana recently concluded its first day, marking a significant milestone in the field of lymphoma research and diagnostics. The event featured contributions from St. Anna CCRI’s  scientists, Margarita Maurer-Granofszky and Anna-Maria Husa, who led insightful workshops focused on high-end

Childhood Cancer Awareness Month 2023 (Vienna, 01.09.2023) Throughout the year, we are committed to raising awareness about childhood cancer, which fundamentally differs from adult cancer. Every September, during Childhood Cancer Awareness Month, we think of something special to go the extra mile. This year we interviewed our young cancer researchers, delving deeper into the personal